KENICHI TANAKA, M.D.
Anesthesiologist Assistant in Atlanta, GA
License number
Georgia 045348
Category
Osteopathic Medicine
Type
Anesthesiology
Address
Address
1364 NE 3B SOUTH EUH, Atlanta, GA 30322
Phone
(404) 778-3900
(404) 778-5194 (Fax)
(404) 778-5194 (Fax)
Professional information
Dr. Kenichi Tanaka, Pittsburgh PA - MD (Doctor of Medicine)
Specialties:
Anesthesiology
Address:
200 Lothrop St, Pittsburgh 15213
EMORY UNIVERSITY HOSPITAL
1364 Clifton Rd NE, Atlanta 30322
(404) 778-7777 (Phone), (404) 778-5194 (Fax)
UNIVERSITY OF PITTSBURGH
200 Lothrop St STE D-132, Pittsburgh 15213
(412) 647-8393 (Phone), (724) 258-1290 (Fax)
EMORY UNIVERSITY HOSPITAL
1364 Clifton Rd NE, Atlanta 30322
(404) 778-7777 (Phone), (404) 778-5194 (Fax)
UNIVERSITY OF PITTSBURGH
200 Lothrop St STE D-132, Pittsburgh 15213
(412) 647-8393 (Phone), (724) 258-1290 (Fax)
Certifications:
Anesthesiology, 1999
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
200 Lothrop St, Pittsburgh 15213
EMORY UNIVERSITY HOSPITAL
1364 Clifton Rd NE, Atlanta 30322
UNIVERSITY OF PITTSBURGH
200 Lothrop St STE D-132, Pittsburgh 15213
Emory University Hospital
1364 Clifton Rd North #East, Atlanta 30322
EMORY UNIVERSITY HOSPITAL
1364 Clifton Rd NE, Atlanta 30322
UNIVERSITY OF PITTSBURGH
200 Lothrop St STE D-132, Pittsburgh 15213
Emory University Hospital
1364 Clifton Rd North #East, Atlanta 30322
Education:
Medical School
Keio Gijuku University / School of Medicine
Beth Israel Medical Center-Petrie Campus
U Pittsburgh Med Ctr
Keio Gijuku University / School of Medicine
Beth Israel Medical Center-Petrie Campus
U Pittsburgh Med Ctr
Kenichi Tanaka M.Sc, Atlanta GA
Specialties:
Anesthesiology
Work:
Emory University Hospital
1364 Clifton Rd Ne, Atlanta, GA 30322
1364 Clifton Rd Ne, Atlanta, GA 30322
Education:
Emory University(1992)
Use Of Thrombin Mutants To Inhibit The Anticoagulation Effect Of Thrombin Inhibitors
US Patent:
2010015, Jun 24, 2010
Filed:
Mar 15, 2007
Appl. No.:
12/282695
Inventors:
Kenichi Tanaka - Atlanta GA, US
Enrico Di Cera - Ladue MO, US
Andras Gruber - Portland OR, US
Stephen Raymond Hanson - Beaverton OR, US
Enrico Di Cera - Ladue MO, US
Andras Gruber - Portland OR, US
Stephen Raymond Hanson - Beaverton OR, US
International Classification:
A61K 38/48, G01N 33/53, A61P 7/04
US Classification:
424 9464, 435 71
Abstract:
The present invention provides methods for inhibiting the anticoagulation effect of a thrombin inhibitor in a patient in need thereof comprising administration of a therapeutically effective amount of a variant prothrombin or thrombin that is capable of binding the thrombin inhibitor and that has reduced procoagulant activity. Variant prothrombins or thrombins of use in the methods of the present invention include thrombin mutants W215A, W215A/E217A, or variants thereof in which the amino acids at positions 215 and/or 217 are alanine. Methods are also provided in which the thrombin mutants are administered with an additional active agent, particularly hemostatic agents such as activated factor VII or activated prothrombin complex concentrate. In one embodiment of the invention, the methods are useful in the treatment of patients in which a direct thrombin inhibitor has been administered, particularly argatroban. The present invention further provides a method for quantifying the concentration of an anticoagulant in the plasma or whole blood of a patient using a variant prothrombin or thrombin titration assay.
Methods Of Managing The Blood Coagulation And Pharmaceutical Compositions Related Thereto
US Patent:
2012005, Mar 1, 2012
Filed:
Aug 29, 2011
Appl. No.:
13/219768
Inventors:
Kenichi Tanaka - Atlanta GA, US
Jerrold H. Levy - Alanta GA, US
Fania Szlam - Norcross GA, US
Jerrold H. Levy - Alanta GA, US
Fania Szlam - Norcross GA, US
Assignee:
EMORY UNIVERSITY - Atlanta GA
International Classification:
A61K 38/10, A61P 7/02, A61K 31/7088, A61K 31/702, A61K 39/395
US Classification:
4241301, 514 137, 514 54, 514 44 R
Abstract:
The disclosure relates to methods of managing blood coagulation and pharmaceutical compositions related thereto. In certain embodiments, the disclosure relates to methods of managing the coagulation of blood in a patient undergoing surgery comprising administering combinations of a direct thrombin inhibitor and a coagulation factor inhibitor. In some embodiments, the disclosure relates to treating or preventing clotting by administering compositions disclosed herein to a subject at risk for, exhibiting symptoms of, or diagnosed with a blood clot.